UA80338C2 - N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them - Google Patents

N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them Download PDF

Info

Publication number
UA80338C2
UA80338C2 UAA200511011A UAA200511011A UA80338C2 UA 80338 C2 UA80338 C2 UA 80338C2 UA A200511011 A UAA200511011 A UA A200511011A UA A200511011 A UAA200511011 A UA A200511011A UA 80338 C2 UA80338 C2 UA 80338C2
Authority
UA
Ukraine
Prior art keywords
pyrrolidin
ylbenzamide
dichloro
isobutyl
alkyl
Prior art date
Application number
UAA200511011A
Other languages
English (en)
Ukrainian (uk)
Inventor
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27636730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA80338(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2004/001943 external-priority patent/WO2004110995A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of UA80338C2 publication Critical patent/UA80338C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
UAA200511011A 2003-06-17 2004-07-06 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them UA80338C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314048.0A GB0314048D0 (en) 2003-06-17 2003-06-17 Novel compounds
PCT/IB2004/001943 WO2004110995A1 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Publications (1)

Publication Number Publication Date
UA80338C2 true UA80338C2 (en) 2007-09-10

Family

ID=27636730

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200511011A UA80338C2 (en) 2003-06-17 2004-07-06 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them

Country Status (9)

Country Link
CN (1) CN1835921A (sr)
GB (1) GB0314048D0 (sr)
GT (1) GT200400121A (sr)
NO (1) NO20060190L (sr)
OA (1) OA13178A (sr)
RS (1) RS20050924A (sr)
TN (1) TNSN05321A1 (sr)
UA (1) UA80338C2 (sr)
ZA (1) ZA200509132B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5484069B2 (ja) * 2007-12-19 2014-05-07 大日本住友製薬株式会社 二環性へテロ環誘導体

Also Published As

Publication number Publication date
ZA200509132B (en) 2007-02-28
NO20060190L (no) 2006-01-12
GT200400121A (es) 2005-03-03
CN1835921A (zh) 2006-09-20
OA13178A (en) 2006-12-13
TNSN05321A1 (fr) 2007-07-10
RS20050924A (sr) 2008-04-04
GB0314048D0 (en) 2003-07-23

Similar Documents

Publication Publication Date Title
EP1638933B1 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
JP6966590B2 (ja) オメカムチブメカルビルの塩及び塩を調製するプロセス
KR100896838B1 (ko) 모폴린 화합물
EP2635580B1 (en) Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
US6630504B2 (en) Phenoxyphenylheterocyclyl derivatives as SSRIs
UA80338C2 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them
MXPA01008860A (es) Derivados de fenoxifenilheterociclilo como inhibidores selectivos de la recaptacion de serotonina.
JP2007517855A (ja) セロトニン及びノルアドレナリン再取込み阻害剤としての活性を示すピペラジン誘導体
TW201908320A (zh) 一種ｂｔｋ激酶抑制劑的結晶形式及製備方法
JP2020536941A (ja) 疼痛及び疼痛に関連する状態を治療するためのプロパンアミン誘導体
KR100871272B1 (ko) 모폴린 화합물
WO2024217521A1 (zh) 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物枸橼酸盐的晶型、制备方法及其应用
MXPA06008019A (en) Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-upatke inhibitors